HKScan Oyj Series A
HKFoods Oyj operates as a food company in Finland and Poland. The company produces, sells, and markets pork, beef, poultry, meat products, and ready meals and meal components meals; and processed meats and convenience food under the HK, Kariniemen, Via, Boltsi, Tamminen, Kivikylä, and Rose brands to retail, food service, industry, and export sectors. It also exports its products internationally. … Read more
HKScan Oyj Series A (0ISM) - Total Liabilities
Latest total liabilities as of March 2024: €402.00 Million EUR
Based on the latest financial reports, HKScan Oyj Series A (0ISM) has total liabilities worth €402.00 Million EUR as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
HKScan Oyj Series A - Total Liabilities Trend (2002–2023)
This chart illustrates how HKScan Oyj Series A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
HKScan Oyj Series A Competitors by Total Liabilities
The table below lists competitors of HKScan Oyj Series A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Southern Score Builders Berhad
KLSE:0045
|
Malaysia | RM118.76 Million |
|
NOVAREX Co.Ltd
KQ:194700
|
Korea | ₩97.40 Billion |
|
Ci&T Inc
NYSE:CINT
|
USA | $1.32 Billion |
|
First Real Estate Investment Trust of New Jersey Inc
PINK:FREVS
|
USA | $124.17 Million |
|
Dinhvu Port Investment Development JSC
VN:DVP
|
Vietnam | ₫97.30 Billion |
|
Kyeryong Const
KO:013580
|
Korea | ₩2.19 Trillion |
|
Ryvu Therapeutics SA
WAR:RVU
|
Poland | zł184.12 Million |
|
Itafos Inc
PINK:MBCF
|
USA | $383.35 Million |
Liability Composition Analysis (2002–2023)
This chart breaks down HKScan Oyj Series A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HKScan Oyj Series A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HKScan Oyj Series A (2002–2023)
The table below shows the annual total liabilities of HKScan Oyj Series A from 2002 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €639.60 Million | -7.17% |
| 2022-12-31 | €689.00 Million | +5.16% |
| 2021-12-31 | €655.20 Million | +1.30% |
| 2020-12-31 | €646.80 Million | +5.95% |
| 2019-12-31 | €610.50 Million | +0.86% |
| 2018-12-31 | €605.30 Million | +0.60% |
| 2017-12-31 | €601.70 Million | +35.18% |
| 2016-12-31 | €445.10 Million | +8.17% |
| 2015-12-31 | €411.50 Million | -1.81% |
| 2014-12-31 | €419.10 Million | -43.81% |
| 2013-12-31 | €745.90 Million | -8.62% |
| 2012-12-31 | €816.30 Million | -1.83% |
| 2011-12-31 | €831.50 Million | -0.85% |
| 2010-12-31 | €838.60 Million | +24.18% |
| 2009-12-31 | €675.30 Million | -12.62% |
| 2008-12-31 | €772.80 Million | -3.17% |
| 2007-12-31 | €798.10 Million | +155.47% |
| 2006-12-31 | €312.40 Million | +9.85% |
| 2005-12-31 | €284.40 Million | +32.48% |
| 2004-12-31 | €214.67 Million | -3.44% |
| 2003-12-31 | €222.32 Million | +9.86% |
| 2002-12-31 | €202.38 Million | -- |